Stock Selection: DeepSeek's picks for 2026-11-03

DeepSeek picked UPWK, TEVA, AEHR, HLIT, ON for a 1-day horizon. Portfolio return vs SPY: -4.82%. Picks that beat SPY: 0%.

ExperimentStock Selection
ModelDeepSeek
Prompt versionstock-selection-v8
Asked
Horizon1-day
Measured from2026-11-03
Measured to2026-11-04
BenchmarkSPY
StatusSettled
Portfolio return vs SPY-4.82%
Picks that beat SPY0%
Benchmark return+1.19%

The picks

RankSymbolReturnConfidencevs benchmarkCalled right
1UPWK-0.19%70%-1.38%No
2TEVA-0.40%65%-1.59%No
3AEHR-6.88%63%-8.07%No
4HLIT-6.46%60%-7.65%No
5ON-4.24%58%-5.43%No

The model's market view

US equities are digesting a heavy earnings morning. Several companies that beat estimates and raised guidance are seeing strong follow-through buying, while others that beat but failed to raise are being sold. I favor clean post-earnings continuation stories where the fundamental surprise is large, volume is orderly, and the stock is not already at an extreme. I avoid names where the initial premarket gain has fully faded, and I avoid index-driven or merger-driven moves.

Why each pick

UPWK

Upwork reported Q3 2026 revenue of $185.6 million and adjusted EPS of $0.40, beating estimates, and raised full-year adjusted EPS guidance to $1.46 at the midpoint. The stock jumped 14.7% on November 2 and continued higher to $10.85 on November 3. The catalyst is a clean fundamental beat with a guidance raise, supported by a higher take rate and strong Business Plus and AI demand. The stock remains far below its 52-week high, leaving room for further recovery. Risks: revenue declined 8% year-over-year, and the core marketplace is shrinking; the stock could face resistance after a two-day surge. Reference price $10.85 is an intraday quote from November 3 (Robinhood).

TEVA

Teva reported Q3 2026 adjusted EPS of $0.86 versus the $0.72 consensus and revenue of $4.4 billion versus the $4.25 billion estimate, and raised its full-year outlook. The stock rose 4-5% to a record high. The beat was driven by 33% growth in key innovative brands (AUSTEDO, AJOVY, UZEDY) and gross-margin expansion, a genuine improvement in the business mix rather than a one-off. The guidance raise supports continued earnings momentum, and the stock is in blue-sky territory with no overhead resistance. Risks: the stock is at an all-time high, so profit-taking is possible, and generic-drug pricing pressure remains a structural headwind. Reference price $42.65 is an intraday quote from November 3 (Investing.com).

AEHR

Aehr Test Systems reported fiscal Q1 2027 non-GAAP EPS of $0.28 versus the $0.11 consensus, revenue up 200% year-over-year, and raised FY27 revenue guidance to $150 million. The stock surged 15-19% on November 3. The catalyst is a massive fundamental beat driven by accelerating AI-chip burn-in demand, and it changes near-term business expectations rather than merely reflecting sentiment. The move is supported by backlog above $100 million. Risks: the stock is highly volatile with a wide intraday range, and profit-taking could cap further upside; the semiconductor-test niche is cyclical. Reference price $58.67 is an intraday quote from November 3 (Robinhood).

HLIT

Harmonic reported Q3 2026 revenue of $148.8 million, up 64% year-over-year and well above the high end of guidance, and raised its full-year 2026 revenue outlook to $545-555 million. The stock jumped 17% on the news. Revenue growth is exceptional, driven by the Rest-of-Market segment more than doubling year-over-year to a record 46% of total revenue. The catalyst is substantive and reflects real business momentum. Risks: adjusted EPS of $0.16 missed the $0.17 consensus by a penny, and the stock may have overreacted to the revenue beat; the small-cap name can be volatile. Reference price $11.95 is an intraday quote from November 3 (Robinhood).

ON

ON Semiconductor reported Q3 2026 adjusted EPS of $0.90 versus the $0.87 consensus and revenue of $1.72 billion versus the $1.70 billion estimate, and guided Q4 EPS to $0.95-$1.07, above the $0.88 consensus. AI data center revenue surged 175% year-over-year. The stock is up 2.18% to $70.11, a more modest and orderly move than the other picks, which leaves room for continued re-rating as the market digests the AI growth story and the above-consensus guidance. Risks: automotive end-market weakness persists, and semiconductor cyclicality could pressure the stock if the broader sector sells off. Reference price $70.11 is a delayed intraday quote from November 3 (Yahoo Finance).

Other models on the same run

ModelPicksPortfolio return vs SPYPicks that beat SPY
Claude Opus 5.5FISV, IDXX, HWM, RVTY, FN-3.75%40%
Claude Sonnet 5.5OKTA, IDXX, FN, TEM, AMD-3.70%20%
GPT-6FN, HWM, NXT, AMD, IDXX-1.50%40%
GPT-6.1 SolIDXX, REGN, FN, HWM, NXT-1.52%40%
Muse Spark 1.1AMD, IDXX, SHOP, SUPN, LITE-3.31%40%
PerplexityIDXX, HWM, RIVN, PNR, SHW+0.66%80%
Gemini 3 ProAEHR, FN, NBIX, RVTY, LSCC-7.06%0%
Grok 4.7IDXX, LSCC, NBIX, FN, RVTY-4.97%20%

Written up on ForecastNest Insights: Stock Selection: DeepSeek's picks for 2026-11-03.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.